Medical Condition News

RSS

MRI texture features can predict response to neoadjuvant chemotherapy in patients with breast cancer

Oncotarget published "MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer" which reported that the authors investigated whether pre-treatment T2-weighted magnetic resonance imaging can be used to predict response to neoadjuvant chemotherapy in breast cancer.

6 Aug 2021

New immunotherapy strategy can eliminate pancreatic tumors in mice

Pancreatic cancer, which affects about 60,000 Americans every year, is one of the deadliest forms of cancer. After diagnosis, fewer than 10 percent of patients survive for five years.

6 Aug 2021

Study examines the effect of vitamin D supplementation on kidney health in adults with prediabetes

A recent clinical trial described in CJASN has examined the potential of vitamin D supplementation for protecting the kidney health of individuals with pre-diabetes.

6 Aug 2021

Learn & Lounge helps AYA patients, survivors to connect with peers and get support

Young cancer patients face unique challenges. That's why the UC Davis Comprehensive Cancer Center started an Adolescent and Young Adult (AYA) Oncology Program in 2020.

6 Aug 2021

Topical cream shows signs of clinical efficacy in patients with basal cell carcinoma

Remetinostat, a topical cream and first-in-class inhibitor of histone deacetylation, showed signs of clinical efficacy in patients with basal cell carcinoma.

6 Aug 2021

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

The recent US Food and Drug Administration (FDA) approval of aducanumab – which has the potential to treat Alzheimer's disease – may provide a proof of concept that can be rapidly improved upon, writes Dennis Selkoe in this Perspective.

6 Aug 2021

FDA approves an intravenous medication to treat patients with Pompe disease

Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with late-onset Pompe disease.

6 Aug 2021

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Given the progress in therapeutics for Alzheimer's disease (AD), including the recent approval of aducanumab – the first anti-amyloid immunotherapy approved by the FDA for the disease – there is a need for simple blood tests that could be used to ensure accurate diagnosis and assess therapeutic progress.

6 Aug 2021

Using circulating tumor DNA to detect urothelial cancer relapse could help improve treatment

Using circulating tumor DNA to identify patients at risk of urothelial cancer relapse after surgical resection could help improve post-surgery treatment.

6 Aug 2021

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Boosting the function of natural killer cells with magnetic nanoparticles could make cancer immunotherapy more efficient.

6 Aug 2021

Dialysis patients' response to COVID19 vaccine type

The researchers at Standford University evaluated the humoral vaccination response of 2,099 fully vaccinated patients undergoing dialysis.

5 Aug 2021

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

Immunohistochemistry staining showing PD1 expression on tumor cells in a skin biopsy from a cutaneous T-cell lymphoma patient.

5 Aug 2021

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Shuo Ma, MD, '00 PhD, associate professor of Medicine in the Division of Hematology and Oncology, was co-first author of the clinical trial published in Blood.

5 Aug 2021

COVID-19 vaccination offers significant protection for solid organ transplant recipients

In a Brief Communication, published July 29, 2021 in the journal Transplant Infectious Disease, a team of physician-scientists at University of California San Diego School of Medicine found that solid organ transplant recipients who were vaccinated experienced an almost 80 percent reduction in the incidence of symptomatic COVID-19 compared to unvaccinated counterparts during the same time.

5 Aug 2021

Research suggests potential new treatment strategy for phenylketonuria

Researchers at The University of Texas MD Anderson Cancer Center have discovered a critical new factor in regulating phenylalanine metabolism and, therefore, in preventing the inherited metabolic disorder phenylketonuria (PKU).

5 Aug 2021

Experimental drug combination extends survival in mice with lung cancer, study finds

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.

5 Aug 2021

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Stroke patients were almost twice as likely to be functionally independent - mobile and able to perform daily tasks - at 90 days post-stroke if they were treated by a specialized mobile stroke team that traveled to them to perform mechanical clot removal, compared to those who were transferred to a thrombectomy stroke center, according to research conducted within the Mount Sinai Health System and published today in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

5 Aug 2021

Low glycemic diet results in important improvements for people with diabetes

For people with diabetes, sticking to a low glycemic diet results in small but important improvements in blood sugar levels, cholesterol, weight and other risk factors, finds a study published by The BMJ today.

5 Aug 2021

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

The COVID-19 pandemic has significantly altered the delivery of health care including neuropsychological evaluations.

5 Aug 2021

CHEST releases new clinical guidelines for management of venous thromboembolism

The American College of Chest Physicians recently released new clinical guidelines for venous thromboembolism management, "Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel," that provides 29 recommendations on 17 Patients, Interventions, Comparators, Outcomes (PICO) questions, four of which have not been addressed previously.

5 Aug 2021

Medical Condition News

MRI texture features can predict response to neoadjuvant chemotherapy in patients with breast cancer

New immunotherapy strategy can eliminate pancreatic tumors in mice

Study examines the effect of vitamin D supplementation on kidney health in adults with prediabetes

Learn & Lounge helps AYA patients, survivors to connect with peers and get support

Topical cream shows signs of clinical efficacy in patients with basal cell carcinoma

Aducanumab approval for Alzheimer's may provide a proof of concept that can be rapidly improved upon

FDA approves an intravenous medication to treat patients with Pompe disease

Expert highlights the progress and challenges in developing blood tests for Alzheimer's disease

Using circulating tumor DNA to detect urothelial cancer relapse could help improve treatment

Magnetic nanoparticles could enhance the efficacy of cancer immunotherapy

Dialysis patients' response to COVID19 vaccine type

PD1 gene deletions associated with worse prognoses of cutaneous T-cell lymphomas

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

COVID-19 vaccination offers significant protection for solid organ transplant recipients

Research suggests potential new treatment strategy for phenylketonuria

Experimental drug combination extends survival in mice with lung cancer, study finds

Mobile interventional stroke team travels to patients for providing faster access to surgical treatment

Low glycemic diet results in important improvements for people with diabetes

Digital technology may become a standard tool for neuropsychological evaluations after COVID-19

CHEST releases new clinical guidelines for management of venous thromboembolism

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News